Global Sustained Release Excipients Market

Sustained Release Excipients Market Size, Share, Growth Analysis, By Type (Gelatin, Polymers), By Technology (Targeted Delivery, Microencapsulation), By Route of Administration (Oral, Intramuscular), By Region - Industry Forecast 2026-2033

Report ID: SQMIG35I2231 | Region: Global | Published Date: February, 2025
Pages: 157 | Tables: 96 | Figures: 76

Share your requirements to help us to customize the report.
   I acknowledge that I have read the Privacy Policy
Confidentiality

We respect your privacy rights and safeguard your personal information. We prevent the disclosure of personal information to third parties.

Our Clients

  • Schineder Electric
  • KSIA - Korea Semiconductor Industry Association
  • Hitachi Astemo Limited
  • Samsung Electronics
  • Halvo holdings
  • NTT corporation
  • AGC Inc
  • Siemens AG
  • Unilever
  • Merck Pharmaceuticals
  • Atlas Copco
  • Hologic - Medical Technology company
  • Novartis
  • Henkel
  • Reckitt
  • Schineder Electric
  • KSIA - Korea Semiconductor Industry Association
  • Hitachi Astemo Limited
  • Samsung Electronics
  • Halvo holdings
  • NTT corporation
  • AGC Inc
  • Siemens AG
  • Unilever
  • Merck Pharmaceuticals
  • Atlas Copco
  • Hologic - Medical Technology company
  • Novartis
  • Henkel
  • Reckitt

    • FAQs

    Sustained Release Excipients Market size was valued at USD 1.73 Billion in 2024 and is poised to grow from USD 1.87 Billion in 2025 to USD 3.49 Billion by 2033, growing at a CAGR of 8.1% during the forecast period (2026–2033).

    The competitive landscape in the market is defined by the several companies engaged in fierce competition to gain a competitive advantage by focusing on R&D to develop new excipient formulations and delivery systems. Market players are employing strategic partnerships and acquisitions to expand their reach. 'International Flavors & Fragrances Inc. (United States)', 'Evonik Industries AG (Germany) ', 'BASF SE (Germany) ', 'Kerry Group Plc (Ireland) ', 'Roquette Freres (France) ', 'Merck KGaA (Germany) ', 'Associated British Foods Plc (United Kingdom) ', 'ADM (United States) ', 'Wacker Chemie AG (Germany) ', 'Croda International Plc (United Kingdom) ', 'Gattefossé (France) ', 'Colorcon Inc. (United States) ', 'AstraZeneca PLC (United Kingdom) ', 'GlaxoSmithKline PLC (United Kingdom) ', 'Mayne Pharma Group Limited (Australia) ', 'Sun Pharmaceutical Industries Ltd. (India) ', 'Pfizer Inc. (United States) ', 'Novartis AG (Switzerland)'

    The constantly aging population is driving this market as the global demographic landscape shifts to an older age population, propelling demand for healthcare products and pharmaceuticals. Sustained release excipients provide benefits like extended drug release to improve compliance and manage chronic conditions effectively, cementing its importance producing medications that cater to the specific needs of elderly patients. As healthcare providers target the healthcare challenges associated with an aging population, this demographic shift will drive steady demand for sustained release excipients in the pharmaceutical sector.

    Increased Focus on Personalized Medicine: The growing emphasis on personalized medicine is trending in the pharmaceutical industry, including the sustained release excipients market. Advances in biomarker identification and genomics are targeting the development of medications designed according to individual patient profiles. Sustained excipients enable precise dosing and prompt timing of optimized release in therapeutic outcomes while minimizing side effects, highlighting its significance in formulation of these personalized drug delivery systems. This trend is in line with the shift towards patient-centric healthcare, driving innovation in excipient formulations and technologies.

    North America dominates the market due to its thriving pharmaceutical industry, enriched by rigorous R&D, making it a global centre for drug formulation. The adoption of sustained release excipients is being driven further by a strong emphasis on patient-centric healthcare and rigid regulatory standards placed to guarantee drug efficiency and safety. The region's position in the market is strengthened by its substantial healthcare expenditure and large presence of renowned pharmaceutical companies.

    Related Reports

    Pharmaceutical Excipients Market
    Buy Now GET FREE SAMPLE
    Release Coatings Market
    Buy Now GET FREE SAMPLE
    Controlled Release Drug Delivery Market
    Buy Now GET FREE SAMPLE
    Excipients Market
    Buy Now GET FREE SAMPLE
    Release Liners Market
    Buy Now GET FREE SAMPLE
    Biopharmaceuticals Excipients Market
    Buy Now GET FREE SAMPLE
    Controlled Release Fertilizers Market
    Buy Now GET FREE SAMPLE
    Mold Release Agents Market
    Buy Now GET FREE SAMPLE

    Feedback From Our Clients

    Global Sustained Release Excipients Market

    Report ID: SQMIG35I2231

    $5,300
    BUY NOW GET FREE SAMPLE